These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 29197543)

  • 1. Role of dopamine D1 receptor in 3-fluoromethamphetamine-induced neurotoxicity in mice.
    Nguyen PT; Shin EJ; Dang DK; Tran HQ; Jang CG; Jeong JH; Lee YJ; Lee HJ; Lee YS; Yamada K; Nabeshima T; Kim HC
    Neurochem Int; 2018 Feb; 113():69-84. PubMed ID: 29197543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methiopropamine, a methamphetamine analogue, produces neurotoxicity via dopamine receptors.
    Nguyen PT; Dang DK; Tran HQ; Shin EJ; Jeong JH; Nah SY; Cho MC; Lee YS; Jang CG; Kim HC
    Chem Biol Interact; 2019 May; 305():134-147. PubMed ID: 30922767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of system Xc
    Dang DK; Shin EJ; Tran HQ; Kim DJ; Jeong JH; Jang CG; Nah SY; Sato H; Nabeshima T; Yoneda Y; Kim HC
    Neurochem Int; 2017 Sep; 108():254-265. PubMed ID: 28457879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic or pharmacological depletion of cannabinoid CB1 receptor protects against dopaminergic neurotoxicity induced by methamphetamine in mice.
    Dang DK; Shin EJ; Mai AT; Jang CG; Nah SY; Jeong JH; Ledent C; Yamamoto T; Nabeshima T; Onaivi ES; Kim HC
    Free Radic Biol Med; 2017 Jul; 108():204-224. PubMed ID: 28363605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ginsenoside Re protects methamphetamine-induced dopaminergic neurotoxicity in mice via upregulation of dynorphin-mediated κ-opioid receptor and downregulation of substance P-mediated neurokinin 1 receptor.
    Dang DK; Shin EJ; Kim DJ; Tran HQ; Jeong JH; Jang CG; Nah SY; Jeong JH; Byun JK; Ko SK; Bing G; Hong JS; Kim HC
    J Neuroinflammation; 2018 Feb; 15(1):52. PubMed ID: 29467000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of oxidative stress in methamphetamine-induced dopaminergic toxicity mediated by protein kinase Cδ.
    Shin EJ; Duong CX; Nguyen XT; Li Z; Bing G; Bach JH; Park DH; Nakayama K; Ali SF; Kanthasamy AG; Cadet JL; Nabeshima T; Kim HC
    Behav Brain Res; 2012 Jun; 232(1):98-113. PubMed ID: 22512859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exposure to Far Infrared Ray Protects Methamphetamine-Induced Behavioral Sensitization in Glutathione Peroxidase-1 Knockout Mice via Attenuating Mitochondrial Burdens and Dopamine D1 Receptor Activation.
    Mai HN; Sharma N; Shin EJ; Nguyen BT; Jeong JH; Jang CG; Cho EH; Nah SY; Kim NH; Nabeshima T; Kim HC
    Neurochem Res; 2018 May; 43(5):1118-1135. PubMed ID: 29687308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apocynin prevents mitochondrial burdens, microglial activation, and pro-apoptosis induced by a toxic dose of methamphetamine in the striatum of mice via inhibition of p47phox activation by ERK.
    Dang DK; Shin EJ; Nam Y; Ryoo S; Jeong JH; Jang CG; Nabeshima T; Hong JS; Kim HC
    J Neuroinflammation; 2016 Jan; 13():12. PubMed ID: 26780950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Striatal dopamine D1 and D2 receptors: widespread influences on methamphetamine-induced dopamine and serotonin neurotoxicity.
    Gross NB; Duncker PC; Marshall JF
    Synapse; 2011 Nov; 65(11):1144-55. PubMed ID: 21584865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of dopamine receptors in the neurotoxicity of methamphetamine.
    Ares-Santos S; Granado N; Moratalla R
    J Intern Med; 2013 May; 273(5):437-53. PubMed ID: 23600399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New recreational drug 1-phenyl-2-(1-pyrrolidinyl)-1-pentanone (alpha-PVP) activates central nervous system via dopaminergic neuron.
    Kaizaki A; Tanaka S; Numazawa S
    J Toxicol Sci; 2014 Feb; 39(1):1-6. PubMed ID: 24418703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutual enhancement of central neurotoxicity induced by ketamine followed by methamphetamine.
    Ke JJ; Chen HI; Jen CJ; Kuo YM; Cherng CG; Tsai YP; Ho MC; Tsai CW; Yu L
    Toxicol Appl Pharmacol; 2008 Mar; 227(2):239-47. PubMed ID: 18076959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The new designer drug buphedrone produces rewarding properties via dopamine D1 receptor activation.
    Oh JH; Hwang JY; Hong SI; Ma SX; Seo JY; Lee SY; Kim HC; Jang CG
    Addict Biol; 2018 Jan; 23(1):69-79. PubMed ID: 27790823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impairment in consolidation of learned place preference following dopaminergic neurotoxicity in mice is ameliorated by N-acetylcysteine but not D1 and D2 dopamine receptor agonists.
    Achat-Mendes C; Anderson KL; Itzhak Y
    Neuropsychopharmacology; 2007 Mar; 32(3):531-41. PubMed ID: 16760923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles of D1 and D2 dopamine receptor subtypes in mediating the methamphetamine-induced changes in monoamine systems.
    Sonsalla PK; Gibb JW; Hanson GR
    J Pharmacol Exp Ther; 1986 Sep; 238(3):932-7. PubMed ID: 2943891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective and restorative effects of the traditional Chinese medicine Jitai tablet against methamphetamine-induced dopaminergic neurotoxicity.
    Xu S; Tu S; Gao J; Liu J; Guo Z; Zhang J; Liu X; Liang J; Huang Y; Han M
    BMC Complement Altern Med; 2018 Feb; 18(1):76. PubMed ID: 29475448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methamphetamine oxidative stress, neurotoxicity, and functional deficits are modulated by nuclear factor-E2-related factor 2.
    Ramkissoon A; Wells PG
    Free Radic Biol Med; 2015 Dec; 89():358-68. PubMed ID: 26427884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methamphetamine neurotoxicity in dopamine nerve endings of the striatum is associated with microglial activation.
    Thomas DM; Walker PD; Benjamins JA; Geddes TJ; Kuhn DM
    J Pharmacol Exp Ther; 2004 Oct; 311(1):1-7. PubMed ID: 15163680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine D2-receptor knockout mice are protected against dopaminergic neurotoxicity induced by methamphetamine or MDMA.
    Granado N; Ares-Santos S; Oliva I; O'Shea E; Martin ED; Colado MI; Moratalla R
    Neurobiol Dis; 2011 Jun; 42(3):391-403. PubMed ID: 21303698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrophysiological verification of the presence of D1 and D2 dopamine receptors within the ventral pallidum.
    Napier TC; Maslowski-Cobuzzi RJ
    Synapse; 1994 Jul; 17(3):160-6. PubMed ID: 7974198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.